
|Videos|August 9, 2022
Factors for Consideration when Choosing an ADT Regimen for mCSPC
Author(s)Jason Hafron, MD
Jason Hafron, MD, revisits the patient profile and discusses factors that inform treatment decision-making in mCSPC.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Choosing salvage therapy after prostate cancer focal ablation
2
Gemcitabine intravesical system delivers high 12-month DFS in papillary-only NMIBC
3
SYNC-T demonstrates high bone metastasis resolution in phase 1 cohort
4
CORE-008: Cretostimogene achieves high CR rate in high-risk NMIBC
5


















